Rydex Series S&P MidCap 400 Pure Growth Fund

Scorecard
4 / 5 Stars
Lipper
5 5 3 5 4
Zacks Investment Research
2 (Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
B (Buy)

Fund Holdings

Asset Allocation

% Long % Short % Net
Cash 0.35 0.0 0.35
Stocks 99.83 0.0 99.83
Bonds 0.0 0.0 0.0
Other 0.0 0.18 -0.18
Foreign Bonds 0.0 0.0 0.0
Foreign Stocks 0.0 0.0 0.0
Convertible 0.0 0.0 0.0
Preferred 0.0 0.0 0.0

Updated 01.31.2014

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 01.31.2014

Ticker YTD Return % % Net Assets
Salix Pharmaceuticals, Ltd. SLXP 23.13 2.5
Synovus Financial Corp SNV -3.33 2.31
Green Mountain Coffee Roasters, Inc. GMCR 45.87 2.3
3D Systems Corporation DDD -19.44 2.1
Trinity Industries, Inc. TRN 30.91 2.05
United Therapeutics Corporation UTHR -11.24 1.99
SVB Financial Group SIVB 16.87 1.92
BancorpSouth Inc. BXS -5.59 1.89
Patterson-UTI Energy, Inc. PTEN 12.84 1.89
Endo Health Solutions Inc ENDP 13.87 1.86